Angiogenesis in lung development, injury and repair: implications for chronic lung disease of prematurity

Bernard Thébaud1

  • 1Vascular Biology Group, Division of Neonatology, Department of Pediatrics, University of Alberta, Edmonton, Alta., Canada. bthebaud@ualberta.ca

Neonatology
|June 19, 2007
PubMed

Insights

Bronchopulmonary dysplasia (BPD) now affects premature infants with arrested alveolar development. Angiogenic growth factors, particularly vascular endothelial growth factor, play a key role in lung development and repair, offering therapeutic targets.

Area of Science:

  • Neonatal medicine
  • Pulmonary biology
  • Developmental biology

Background:

  • Bronchopulmonary dysplasia (BPD) remains a challenge despite advances in perinatal care.
  • Modern BPD affects extremely premature infants, characterized by arrested alveolar development.
  • Signaling mechanisms regulating lung development, especially alveolar and vascular growth, are not fully understood.

Purpose of the Study:

  • To review the role of angiogenic growth factors in normal alveolar development.
  • To explore the involvement of these factors in lung injury and repair processes.
  • To highlight the significance of vascular endothelial growth factor (VEGF) in BPD.

Main Methods:

  • Literature review focusing on recent research in lung development and BPD.
  • Analysis of signaling pathways involved in alveolar and capillary network formation.
  • Emphasis on the role of vascular endothelial growth factor (VEGF) and related pathways.

Main Results:

  • Normal alveolar and capillary development is regulated by complex signaling pathways.
  • Angiogenic factors, including VEGF, are crucial for both normal lung development and repair after injury.
  • Disruption of these pathways contributes to the pathogenesis of BPD in preterm infants.

Conclusions:

  • Understanding angiogenic factor roles is critical for developing novel BPD therapies.
  • Targeting VEGF signaling may offer a promising strategy for treating lung diseases with alveolar damage.
  • Further research into these mechanisms is needed to improve outcomes for premature infants.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...